About Company:

Established in 1981, Vijaya Diagnostic Centre is one of the fastest-growing diagnostic chains in Southern India. The company offers a one-stop solution for pathology and radiology testing services. The company offers around 740 routine tests, 870 specialized pathology tests, 220 basic tests, and 320 advanced radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers.

Company's operational network consists of 80 diagnostic centers and 11 reference laboratories spread across 13 cities and towns in the states of Telangana, Andhra Pradesh, National Capital Region, and Kolkata. 96.2% of the revenue comes from Hyderabad, the rest of Telangana, and the Andhra Pradesh region. During the year ended March 31, 2021, the company conducted approximately 6.20 Mn pathology tests and 0.89 Mn radiology tests for approximately 2.63 Mn customers.

As of March 31, 2021, all Vijaya Diagnostic Centre laboratories hold National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditations, and three diagnostic centers hold Patient Safety & Quality of Care (NABH) accreditations.

Competitive strengths:

• Largest and fastest-growing diagnostic chain in Southern India.
• Affordable, one-stop solution diagnostics service provider with a focus on superior quality.
• Strong technical capabilities, cutting-edge diagnostic testing technology and robust IT infrastructure.
• All laboratories hold National Accreditation.
• High brand recalls driving high individual consumer business.

Company Promoters

Dr. S. Surendranath Reddy is the promoter of the company.

Company Financials:

Objects of the Issue:

The net proceed from the IPO will be utilized towards the following purposes;

• Achieve the benefits of share listing on the Stock Exchanges.
• To make an offer for sale (OFS) of 35,688,064 shares.

IPO Details:

You should apply for it or not ?

Shares of Vijaya Diagnostic are available today at a premium of ₹10 in the grey market, which is almost half of its previous day's grey market premium of ₹18. According to market observers, Vijaya Diagnostic IPO grey market premium has been nose diving in the grey market and it has come down from ₹40 to ₹10 today in the last 5 days.

So seeing On the upper band of ₹531, the asking P/E comes at around 64x which seems to be on higher side, so one can avoid applying or can keen to watch subscription rush and act accordingly.

*investment are subject to market risk, read documents before investing. We are not SEBI registered advisor please consult SEBI advisor regarding same.*